ChiCTR2200065398 版本V1.0 版本创建时间2022/11/03 20:10:53 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200065398 

最近更新日期:

Date of Last Refreshed on:

2022-11-03 20:10:28 

注册时间:

Date of Registration:

2022-11-03 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

青少年近视预测模型在基层医院青少年近视防控中的应用研究

Public title:

Application of prediction model of adolescent myopia in prevention and control of adolescent myopia in primary hospital

注册题目简写:

English Acronym:

研究课题的正式科学名称:

青少年近视预测模型在基层医院青少年近视防控中的应用研究

Scientific title:

Application of prediction model of adolescent myopia in prevention and control of adolescent myopia in primary hospital

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

胡亭 

研究负责人:

胡亭 

Applicant:

Ting,Hu 

Study leader:

Ting,Hu 

申请注册联系人电话:

Applicant telephone:

13522895700

研究负责人电话:

Study leader's
telephone:

13522895700

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

289082977@qq.com

研究负责人电子邮件:

Study leader's E-mail:

289082977@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

北京市延庆区医院(北京大学第三医院延庆医院)

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市延庆区东顺成28号延庆区医院

研究负责人通讯地址:

No. 28 Dongshuncheng, Yanqing District, Beijing, China

Applicant address:

No. 28 Dongshuncheng, Yanqing District, Beijing, China

Study leader's address:

北京市延庆区东顺成28号延庆区医院

申请注册联系人邮政编码:

Applicant postcode:

102100

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京市延庆区医院(北京大学第三医院延庆医院)

Applicant's institution:

Peking University Third Hospital Yanqing Hospital

研究负责人所在单位:

北京市延庆区医院(北京大学第三医院延庆医院)

Affiliation of the Leader:

Peking University Third Hospital Yanqing Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

20223200101

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京市延庆区医院(伦理委员会北京大学第三医院延庆医院)伦理委员会

Name of the ethic committee:

Peking University Third Hospital Yanqing Hospital ethnic committe

伦理委员会批准日期:

Date of approved by ethic committee:

2022-07-29 00:00:00

伦理委员会联系人:

刘丽英

Contact Name of the ethic committee:

LiYing,Liu

伦理委员会联系地址:

北京市延庆区东顺成28号延庆区医院

Contact Address of the ethic committee:

No. 28 Dongshuncheng, Yanqing District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

15901082737

伦理委员会联系人邮箱:

Contact email of the ethic committee:

2490489693@qq.com

研究实施负责(组长)单位:

北京市延庆区医院(北京大学第三医院延庆医院)

Primary sponsor:

Peking University Third Hospital Yanqing Hospital

研究实施负责(组长)单位地址:

北京市延庆区东顺成28号延庆区医院

Primary sponsor's address:

No. 28 Dongshuncheng, Yanqing District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京市延庆区医院(北京大学第三医院延庆医院)

具体地址:

北京市延庆区东顺成28号延庆区医院

Institution
hospital:

Peking University Third Hospital Yanqing Hospital

Address:

28 Dongshuncheng, Yanqing District, Beijing, China

经费或物资来源:

项目经费

Source(s) of funding:

Project funds

研究疾病:

青少年近视  

Target disease:

juvenile myopia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

基于数据挖掘,构建青少年近视发病的风险预测模型,进行近视发病早期识别。根据慢病管理模型理论建立青少年近视人群干预模式,对高风险人群进行管理,研究其在基层医院青少年近视防治中的作用。  

Objectives of Study:

To establish a risk prediction model for myopia in adolescents based on data mining, and to identify myopia in early stage. According to the theory of chronic disease management model, an intervention model for adolescent myopia was established to manage high-risk groups and study its role in the prevention and treatment of adolescent myopia in primary hospitals.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

自愿加入本研究能够配合开展环境因素问卷调查及进行随访观察的小学生。

Inclusion criteria

Primary school students who volunteered to participate in this study and were able to cooperate with the environmental factors questionnaire survey and follow-up observation.

排除标准:

无法散瞳或不能接受散瞳行屈光度测量的受试者。不能长期参与随访者。

Exclusion criteria:

subjects unable to dilate pupils or unable to receive dilated pupils for diopter measurement. Unable to participate in long-term interviews.

研究实施时间:

Study execute time:

From 2022-07-29 00:00:00 To 2024-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-11-15 00:00:00 To 2022-12-31 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

659

Group:

Intervention group

Sample size:

干预措施:

慢病管理模式

干预措施代码:

Intervention:

Chronic disease management model

Intervention code:

组别:

对照组

样本量:

659

Group:

control group

Sample size:

干预措施:

常规管理模式

干预措施代码:

Intervention:

Conventional management

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京市 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京市延庆区医院(北京大学第三医院延庆医院) 

单位级别:

三级医院 

Institution
hospital:

Peking University Third Hospital Yanqing Hospital

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

屈光度

指标类型:

次要指标

Outcome:

diopter

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

新发近视率

指标类型:

主要指标

Outcome:

Rate of new myopia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼轴

指标类型:

主要指标

Outcome:

Eye axis

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 6 years
最大 Max age 9 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由课题组之外人员利用随机数字表产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

Random sequences are generated by people outside the research group using random number tables

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

文章发表

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Article published

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1从相关机器导出数据 2采用相关统计软件进行统计分析

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1 Export data from relevant machines. 2 Use relevant statistical software for statistical analysis

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-11-03 20:10:28